These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 16338251

  • 21. Preventive drug use in patients with a history of nonfatal myocardial infarction during 12-year follow-up in The Netherlands: a retrospective analysis.
    van der Elst ME, Bouvy ML, de Blaey CJ, de Boer A.
    Clin Ther; 2005 Nov; 27(11):1806-14. PubMed ID: 16368451
    [Abstract] [Full Text] [Related]

  • 22. Evidence-based medication and revascularization: powerful tools in the management of patients with diabetes and coronary artery disease: a report from the Euro Heart Survey on diabetes and the heart.
    Anselmino M, Malmberg K, Ohrvik J, Rydén L, Euro Heart Survey Investigators.
    Eur J Cardiovasc Prev Rehabil; 2008 Apr; 15(2):216-23. PubMed ID: 18391651
    [Abstract] [Full Text] [Related]

  • 23. [Reduction in acute myocardial infarction mortality over a five-year period].
    Heras M, Marrugat J, Arós F, Bosch X, Enero J, Suárez MA, Pabón P, Ancillo P, Loma-Osorio A, Rodríguez JJ, Subirana I, Vila J, en representación de los investigadores del estudio PRIAMHO.
    Rev Esp Cardiol; 2006 Mar; 59(3):200-8. PubMed ID: 16712743
    [Abstract] [Full Text] [Related]

  • 24. Use of combination evidence-based medical therapy prior to acute myocardial infarction (from the National Registry of Myocardial Infarction-4).
    Spencer FA, Frederick PD, Goldberg RJ, Gore JM, Tiefenbrunn AJ, National Registry of Myocardial Infarction-4 Investigators.
    Am J Cardiol; 2005 Oct 01; 96(7):922-6. PubMed ID: 16188517
    [Abstract] [Full Text] [Related]

  • 25. Long-term compliance with beta-blockers, angiotensin-converting enzyme inhibitors, and statins after acute myocardial infarction.
    Gislason GH, Rasmussen JN, Abildstrøm SZ, Gadsbøll N, Buch P, Friberg J, Rasmussen S, Køber L, Stender S, Madsen M, Torp-Pedersen C.
    Eur Heart J; 2006 May 01; 27(10):1153-8. PubMed ID: 16399775
    [Abstract] [Full Text] [Related]

  • 26. Effect of renin-angiotensin system inhibitors on long-term survival in patients treated with beta blockers and antiplatelet agents after acute myocardial infarction (from the MONICA/KORA Myocardial Infarction Registry).
    Amann U, Kirchberger I, Heier M, Zirngibl A, von Scheidt W, Kuch B, Peters A, Meisinger C.
    Am J Cardiol; 2014 Aug 01; 114(3):329-35. PubMed ID: 24927969
    [Abstract] [Full Text] [Related]

  • 27. Invasive vs non-invasive treatment in acute coronary syndromes and prior bypass surgery.
    Gurfinkel EP, Perez de la Hoz R, Brito VM, Duronto E, Dabbous OH, Gore JM, Anderson FA, GRACE Investigators.
    Int J Cardiol; 2007 Jun 25; 119(1):65-72. PubMed ID: 17045681
    [Abstract] [Full Text] [Related]

  • 28. Predictors of long-term use of evidence-based therapies after non-ST-segment elevation acute coronary syndrome. The S-Témoin survey.
    Danchin N, Diévart F, Thébaut JF, Grenier O, Mihci E, Herrmann MA, Ferrières J.
    Int J Cardiol; 2009 Mar 20; 133(1):32-40. PubMed ID: 18375000
    [Abstract] [Full Text] [Related]

  • 29. Association of early follow-up after acute myocardial infarction with higher rates of medication use.
    Daugherty SL, Ho PM, Spertus JA, Jones PG, Bach RG, Krumholz HM, Peterson ED, Rumsfeld JS, Masoudi FA.
    Arch Intern Med; 2008 Mar 10; 168(5):485-91; discussion 492. PubMed ID: 18332293
    [Abstract] [Full Text] [Related]

  • 30. Impact of medication therapy discontinuation on mortality after myocardial infarction.
    Ho PM, Spertus JA, Masoudi FA, Reid KJ, Peterson ED, Magid DJ, Krumholz HM, Rumsfeld JS.
    Arch Intern Med; 2006 Sep 25; 166(17):1842-7. PubMed ID: 17000940
    [Abstract] [Full Text] [Related]

  • 31. Preoperative statin therapy is associated with reduced cardiac mortality after coronary artery bypass graft surgery.
    Collard CD, Body SC, Shernan SK, Wang S, Mangano DT, Multicenter Study of Perioperative Ischemia (MCSPI) Research Group, Inc, Ischemia Research and Education Foundation (IREF) Investigators.
    J Thorac Cardiovasc Surg; 2006 Aug 25; 132(2):392-400. PubMed ID: 16872968
    [Abstract] [Full Text] [Related]

  • 32. Pharmacological treatment after acute myocardial infarction from 2001 to 2006: a survey in Italian primary care.
    Filippi A, D'Ambrosio G, Giustini SE, Pecchioli S, Mazzaglia G, Cricelli C.
    J Cardiovasc Med (Hagerstown); 2009 Sep 25; 10(9):714-8. PubMed ID: 19465867
    [Abstract] [Full Text] [Related]

  • 33. Secondary prevention after acute myocardial infarction in four Canadian provinces, 1997-2000.
    Pilote L, Beck CA, Karp I, Alter D, Austin P, Cox J, Humphries K, Jackevicius C, Richard H, Tu JV, Canadian Cardiovascular Outcomes Research Team.
    Can J Cardiol; 2004 Jan 25; 20(1):61-7. PubMed ID: 14968144
    [Abstract] [Full Text] [Related]

  • 34. Factors associated with the use of evidence-based therapies after discharge among elderly patients with myocardial infarction.
    Austin PC, Tu JV, Ko DT, Alter DA.
    CMAJ; 2008 Oct 21; 179(9):901-8. PubMed ID: 18936455
    [Abstract] [Full Text] [Related]

  • 35. Secondary medical prevention among Danish patients hospitalised with either peripheral arterial disease or myocardial infarction.
    Gasse C, Jacobsen J, Larsen AC, Schmidt EB, Johannesen NL, Videbaek J, Sørensen HT, Johnsen SP.
    Eur J Vasc Endovasc Surg; 2008 Jan 21; 35(1):51-8. PubMed ID: 17923426
    [Abstract] [Full Text] [Related]

  • 36. Effect of age on the use of evidence-based therapies for acute myocardial infarction.
    Tran CT, Laupacis A, Mamdani MM, Tu JV.
    Am Heart J; 2004 Nov 21; 148(5):834-41. PubMed ID: 15523314
    [Abstract] [Full Text] [Related]

  • 37. Quality of care for secondary prevention for patients with coronary heart disease: results of the Hastening the Effective Application of Research through Technology (HEART) trial.
    Goff DC, Gu L, Cantley LK, Sheedy DJ, Cohen SJ.
    Am Heart J; 2003 Dec 21; 146(6):1045-51. PubMed ID: 14660997
    [Abstract] [Full Text] [Related]

  • 38. Treatment and secondary prevention of ischemic coronary events in Croatia (TASPIC-CRO study).
    Reiner Z, Mihatov S, Milicić D, Bergovec M, Planinc D, TASPIC-CRO Study Group Investigators.
    Eur J Cardiovasc Prev Rehabil; 2006 Aug 21; 13(4):646-54. PubMed ID: 16874158
    [Abstract] [Full Text] [Related]

  • 39. Prognostic impact of acute beta-blocker therapy on top of aspirin and angiotensin-converting enzyme inhibitor therapy in consecutive patients with ST-elevation acute myocardial infarction.
    Wienbergen H, Zeymer U, Gitt AK, Juenger C, Schiele R, Heer T, Towae F, Senges J, MITRA PLUS Study Group.
    Am J Cardiol; 2007 May 01; 99(9):1208-11. PubMed ID: 17478143
    [Abstract] [Full Text] [Related]

  • 40. [Reduction of in-hospital mortality and improved secondary prevention after acute myocardial infarction. First results from the registry of secondary prevention after acute myocardial infarction (SAMI)].
    Tebbe U, Messer C, Stammwitz E, The GS, Dietl J, Bischoff KO, Schulten-Baumer U, Tebbenjohanns J, Gohlke H, Bramlage P, SAMI Studiengruppe.
    Dtsch Med Wochenschr; 2007 Jul 30; 132(30):1559-66. PubMed ID: 17628839
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.